$AMED
AMEDISYS INC

2015 Q4 Form 10-K Financial Statement

#000119312517063925 Filed on March 01, 2017

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2015 Q2
Revenue $338.4M $326.5M $314.2M
YoY Change 12.61% 8.72% 3.02%
Cost Of Revenue $192.5M $186.8M $175.7M
YoY Change 12.31% 9.76% 1.84%
Gross Profit $145.9M $139.7M $138.5M
YoY Change 12.93% 7.38% 4.53%
Gross Profit Margin 43.11% 42.79% 44.08%
Selling, General & Admin $125.0M $116.2M $118.3M
YoY Change 16.6% 8.19% 5.44%
% of Gross Profit 85.68% 83.18% 85.42%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.200M $4.600M $4.700M
YoY Change -32.26% -29.23% -38.96%
% of Gross Profit 2.88% 3.29% 3.39%
Operating Expenses $129.2M $120.8M $122.9M
YoY Change 13.93% 6.15% 2.5%
Operating Profit $16.70M $16.72M $15.53M
YoY Change 5.7% 2.87% 23.61%
Interest Expense $200.0K $4.936M $2.416M
YoY Change -111.11% 65.08% 78.7%
% of Operating Profit 1.2% 29.53% 15.56%
Other Income/Expense, Net $5.800M -$1.675M $2.912M
YoY Change 286.67% -26.95% -1500.0%
Pretax Income $22.60M $15.04M $18.44M
YoY Change 55.86% 7.77% 49.27%
Income Tax $9.600M $6.465M $7.566M
% Of Pretax Income 42.48% 42.99% 41.03%
Net Earnings $12.90M $8.400M $10.60M
YoY Change 41.76% 0.0% 39.47%
Net Earnings / Revenue 3.81% 2.57% 3.37%
Basic Earnings Per Share $0.39 $0.25 $0.32
Diluted Earnings Per Share $0.38 $0.25 $0.32
COMMON SHARES
Basic Shares Outstanding 33.69M shares 33.13M shares 33.00M shares
Diluted Shares Outstanding 33.63M shares 33.46M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.50M $57.10M $33.20M
YoY Change 243.75% 938.18% 196.43%
Cash & Equivalents $27.50M $57.05M $33.20M
Short-Term Investments
Other Short-Term Assets $22.70M $5.641M $24.70M
YoY Change 15.18% -83.41% -32.88%
Inventory
Prepaid Expenses
Receivables $125.0M $121.7M $110.5M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $175.3M $216.4M $168.4M
YoY Change 29.32% 52.0% 5.98%
LONG-TERM ASSETS
Property, Plant & Equipment $42.70M $41.49M $67.00M
YoY Change -68.94% -70.67% -54.82%
Goodwill $261.7M $211.1M
YoY Change 27.29%
Intangibles $44.00M $33.15M
YoY Change 32.53%
Long-Term Investments
YoY Change
Other Assets $158.0M $164.3M $171.3M
YoY Change 376.46% 3.53% 4.9%
Total Long-Term Assets $506.4M $450.0M $477.0M
YoY Change -5.2% -16.64% -13.49%
TOTAL ASSETS
Total Short-Term Assets $175.3M $216.4M $168.4M
Total Long-Term Assets $506.4M $450.0M $477.0M
Total Assets $681.7M $666.4M $645.4M
YoY Change 1.79% -2.32% -9.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.68M $24.23M $21.90M
YoY Change 59.95% 25.11% 15.87%
Accrued Expenses $71.97M $69.19M $138.8M
YoY Change 27.76% -56.68% -18.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.000M $3.800M $12.00M
YoY Change -58.33% -68.33% -2.44%
Total Short-Term Liabilities $175.2M $171.2M $176.0M
YoY Change 7.93% -10.39% -12.31%
LONG-TERM LIABILITIES
Long-Term Debt $91.60M $96.30M $83.50M
YoY Change -12.26% -5.87% -36.74%
Other Long-Term Liabilities $4.500M $4.998M $5.800M
YoY Change -14.85% -13.05% -10.77%
Total Long-Term Liabilities $91.60M $101.3M $83.50M
YoY Change -16.49% -6.25% -36.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $175.2M $171.2M $176.0M
Total Long-Term Liabilities $91.60M $101.3M $83.50M
Total Liabilities $274.6M $272.5M $266.1M
YoY Change 0.98% -8.91% -21.37%
SHAREHOLDERS EQUITY
Retained Earnings -$67.81M
YoY Change 4.66%
Common Stock $504.3M $495.8M
YoY Change 4.68%
Preferred Stock
YoY Change
Treasury Stock (at cost) $26.97M $22.03M
YoY Change 35.78%
Treasury Stock Shares 1.180M shares 1.054M shares
Shareholders Equity $409.6M $393.1M $379.3M
YoY Change
Total Liabilities & Shareholders Equity $681.7M $666.4M $645.4M
YoY Change 1.79% -2.31% -9.14%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2015 Q2
OPERATING ACTIVITIES
Net Income $12.90M $8.400M $10.60M
YoY Change 41.76% 0.0% 39.47%
Depreciation, Depletion And Amortization $4.200M $4.600M $4.700M
YoY Change -32.26% -29.23% -38.96%
Cash From Operating Activities $20.10M $30.70M $42.50M
YoY Change 336.96% 20.87% -147.65%
INVESTING ACTIVITIES
Capital Expenditures -$3.400M -$1.300M -$14.60M
YoY Change 61.9% 62.5% 305.56%
Acquisitions
YoY Change
Other Investing Activities -$44.10M -$6.700M $4.800M
YoY Change 1370.0% -770.0% -633.33%
Cash From Investing Activities -$47.50M -$8.100M -$9.700M
YoY Change 831.37% -4150.0% 115.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.000M 1.100M -2.700M
YoY Change -164.52% -103.51% -102.65%
NET CHANGE
Cash From Operating Activities 20.10M 30.70M 42.50M
Cash From Investing Activities -47.50M -8.100M -9.700M
Cash From Financing Activities -2.000M 1.100M -2.700M
Net Change In Cash -29.40M 23.70M 30.10M
YoY Change -1230.77% -515.79% 262.65%
FREE CASH FLOW
Cash From Operating Activities $20.10M $30.70M $42.50M
Capital Expenditures -$3.400M -$1.300M -$14.60M
Free Cash Flow $23.50M $32.00M $57.10M
YoY Change 250.75% 22.14% -166.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Liabilities
Liabilities
272887000
CY2016Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
5220000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
63290000
CY2016Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015 us-gaap Cost Of Services
CostOfServices
725915000
CY2015Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
35000
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015 us-gaap Labor And Related Expense
LaborAndRelatedExpense
279425000
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33607282 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25386000
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
26966000
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35253577 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2015Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33597215 shares
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1179684 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34786966 shares
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
11824000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000
CY2015 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
161186000
CY2016 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
19519000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
681715000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
16526000
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
410436000
CY2016Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
35000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
537472000
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
46774000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30545000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
460203000
CY2016Q4 us-gaap Minority Interest
MinorityInterest
939000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
504290000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67806000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
409568000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
138650000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
141793000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27864000
CY2015 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
14053000
CY2016 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
19678000
CY2015 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
20036000
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
1380114000
CY2014 us-gaap Costs And Expenses
CostsAndExpenses
1180507000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
57340000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
24047000
CY2016 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
75000
CY2015 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
71000
CY2016 us-gaap Interest Expense
InterestExpense
5164000
CY2015 us-gaap Interest Expense
InterestExpense
10783000
CY2014 us-gaap Interest Expense
InterestExpense
8217000
CY2016 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5588000
CY2015 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9823000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3727000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9747000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4226000
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8858000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3071000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
61566000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-308000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
20976000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23935000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2004000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7671000
CY2016 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
37631000
CY2015 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-2312000
CY2014 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
13305000
CY2016 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0
CY2015 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0
CY2014 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-216000
CY2016 us-gaap Profit Loss
ProfitLoss
37631000
CY2015 us-gaap Profit Loss
ProfitLoss
-2312000
CY2014 us-gaap Profit Loss
ProfitLoss
13089000
CY2016 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
370000
CY2014 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
313000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
37261000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-3021000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
12776000
CY2016 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.12
CY2015 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.09
CY2014 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.40
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33198000 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33018000 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32301000 shares
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2015 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2014 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2016 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.12
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2016 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
37261000
CY2015 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3021000
CY2014 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
12992000
CY2016 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
CY2015 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
CY2014 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-216000
CY2016 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.10
CY2016 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33741000 shares
CY2015 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.09
CY2015 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33018000 shares
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32823000 shares
CY2014 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2014 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.40
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4432000
CY2015 us-gaap Asset Impairment Charges
AssetImpairmentCharges
77268000
CY2014 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3107000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-9166000
CY2015 us-gaap Costs And Expenses
CostsAndExpenses
1289707000
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2014 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
13089000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12776000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37261000
CY2016 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
37631000
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2015 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2312000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3021000
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
372479000
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2433000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
564000
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5597000
CY2014 us-gaap Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation
579000
CY2015 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2204000
CY2015 amed Stock Issued During Period Value Four Zero One K Employer Match
StockIssuedDuringPeriodValueFourZeroOneKEmployerMatch
6032000
CY2014 amed Surrendered Shares
SurrenderedShares
1684000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
399000
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11824000
CY2015 us-gaap Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation
4000
CY2015 amed Surrendered Shares
SurrenderedShares
2525000
CY2016 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2483000
CY2016 amed Stock Issued During Period Value Four Zero One K Employer Match
StockIssuedDuringPeriodValueFourZeroOneKEmployerMatch
6682000
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16401000
CY2016 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
7241000
CY2016 amed Surrendered Shares
SurrenderedShares
7493000
CY2016 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
12315000
CY2016 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
329000
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
397762000
CY2015 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
2073000
CY2015 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4581000
CY2014 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
1549000
CY2014 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
350000
CY2015 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
436000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19678000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20036000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28347000
CY2016 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
CY2014 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
4233000
CY2016 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
35522000
CY2014 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2015 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
69130000
CY2015 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
413000
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
19519000
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
14053000
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
16369000
CY2016 us-gaap Pension Expense
PensionExpense
6875000
CY2015 us-gaap Pension Expense
PensionExpense
6089000
CY2014 us-gaap Pension Expense
PensionExpense
6216000
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-582000
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-775000
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4592000
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
740000
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
959000
CY2014 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
797000
CY2016 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4323000
CY2015 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5610000
CY2014 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2025000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
55519000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
36493000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5290000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4231000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6455000
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1694000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6269000
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3970000
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7639000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3168000
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7618000
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8406000
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3495000
CY2016 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-726000
CY2016 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
134500000
CY2016 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2483000
CY2015 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2204000
CY2014 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2433000
CY2016 amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
329000
CY2015 amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
436000
CY2014 amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
0
CY2015 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-829000
CY2014 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3226000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
62259000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
107785000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65534000
CY2016 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
230000
CY2015 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
1229000
CY2014 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
11000
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
20000000
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000
CY2016 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0
CY2015 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
19000
CY2014 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
132000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15717000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21429000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12008000
CY2016 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
1040000
CY2015 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
3485000
CY2014 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
6407000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-52049000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-67421000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14300000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
399000
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
564000
CY2015 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
63400000
CY2014 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
241800000
CY2016 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
134500000
CY2015 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
78400000
CY2014 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
226800000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20894000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
70563000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2695000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
19470000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9271000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17303000
CY2016 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
CY2014 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
68250000
CY2016 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2014 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1780000
CY2016 us-gaap Interest Paid
InterestPaid
2897000
CY2014 us-gaap Interest Paid
InterestPaid
7602000
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
755000
CY2014 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1766000
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
100000000
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-12185000
CY2015 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2553000
CY2015 us-gaap Interest Paid
InterestPaid
6175000
CY2014 amed Increase Decrease In Assets Of Equity Method Investment
IncreaseDecreaseInAssetsOfEquityMethodInvestment
0
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4581000
CY2014 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2016 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0
CY2015 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
5000000
CY2014 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0
CY2014 amed Increase Decrease In Us Department Of Justice Settlement Accrual
IncreaseDecreaseInUsDepartmentOfJusticeSettlementAccrual
-150000000
CY2014 amed Write Off Of Investment
WriteOffOfInvestment
0
CY2015 amed Write Off Of Investment
WriteOffOfInvestment
0
CY2016 amed Write Off Of Investment
WriteOffOfInvestment
196000
CY2016 amed Increase Decrease In Assets Of Equity Method Investment
IncreaseDecreaseInAssetsOfEquityMethodInvestment
405000
CY2015 amed Increase Decrease In Assets Of Equity Method Investment
IncreaseDecreaseInAssetsOfEquityMethodInvestment
0
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8032000
CY2016 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
CY2015 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
184000
CY2014 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
2967000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
24547000
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-677000
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
22561000
CY2016 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
7241000
CY2015 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
2073000
CY2014 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
13904000
CY2015 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
103000000
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5000000
CY2016 amed Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
0
CY2015 amed Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
2512000
CY2014 amed Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
488000
CY2016 amed Increase Decrease In Us Department Of Justice Settlement Accrual
IncreaseDecreaseInUsDepartmentOfJusticeSettlementAccrual
0
CY2015 amed Increase Decrease In Us Department Of Justice Settlement Accrual
IncreaseDecreaseInUsDepartmentOfJusticeSettlementAccrual
0
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
11415000
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3523000
CY2016 amed Noncash Or Part Noncash Sale Acquisition Of Noncontrolling Interests
NoncashOrPartNoncashSaleAcquisitionOfNoncontrollingInterests
0
CY2015 amed Noncash Or Part Noncash Sale Acquisition Of Noncontrolling Interests
NoncashOrPartNoncashSaleAcquisitionOfNoncontrollingInterests
0
CY2014 amed Noncash Or Part Noncash Sale Acquisition Of Noncontrolling Interests
NoncashOrPartNoncashSaleAcquisitionOfNoncontrollingInterests
-1549000
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12315000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7515000
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<p style='margin-top:9pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Use of Estimates </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Our accounting and reporting policies conform with U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">G</font><font style="font-family:Times New Roman;font-size:10pt;">enerally Accepted Accounting Principles (&#8220;U.S. G</font><font style="font-family:Times New Roman;font-size:10pt;">AAP</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221;)</font><font style="font-family:Times New Roman;font-size:10pt;">. In preparing the consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates. </font></p><p style='margin-top:9pt; margin-bottom:0pt'>&#160;</p>
CY2016 us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p style='margin-top:9pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Reclassifications and Comparability </font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Certain </font><font style="font-family:Times New Roman;font-size:10pt;">reclassifications have been made to prior periods' financial statements in order to conform to the current period'</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;"> presentation</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">In compliance with Accounting Standards Update (&#8220;ASU&#8221;) 2015-03, </font><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;">Interest &#8211; Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of De</font><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;">bt Issuance Costs, </font><font style="font-family:Times New Roman;font-size:10pt;">we have reclassified 2015 amounts related to unamortized debt issuance costs from other assets, net </font><font style="font-family:Times New Roman;font-size:10pt;">to </font><font style="font-family:Times New Roman;font-size:10pt;">long-term obligations, less current portion</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p style='margin-top:9pt; margin-bottom:0pt'>&#160;</p>
CY2016Q4 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.50 pure
CY2016 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.78 pure
CY2015 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.80 pure
CY2014 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.82 pure
CY2016Q4 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
34 States
CY2015Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
25700000
CY2016Q4 amed Maximum Percent Ownership For Cost Method Percent
MaximumPercentOwnershipForCostMethodPercent
0.20 pure
CY2016Q4 amed Maximum Percent Ownership For Equity Method Percent
MaximumPercentOwnershipForEquityMethodPercent
0.50 pure
CY2016Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
27800000
CY2016Q3 us-gaap Minority Interest Ownership Percentage By Noncontrolling Owners
MinorityInterestOwnershipPercentageByNoncontrollingOwners
0.30 pure
CY2016 amed Episode Of Care As Episodic Based Revenue
EpisodeOfCareAsEpisodicBasedRevenue
60
CY2016 amed Episodes In Progress That Begin During Reporting Period
EpisodesInProgressThatBeginDuringReportingPeriod
60
CY2016 amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 Number_of_Visits
CY2016 amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 Number_of_Visits
CY2016 amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
5 Number_of_Visits
CY2016 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
CY2015 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
CY2014 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98 pure
CY2016 amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.10 pure
CY2016 amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 Number_of_Visits
CY2016 amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99 pure
CY2016 amed Minimum Days Accounts Receivable Outstanding Fully Reserved
MinimumDaysAccountsReceivableOutstandingFullyReserved
365
CY2016 amed Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
0.6 pure
CY2016 amed Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
0.5 pure
CY2016 amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120
CY2016Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
95700000
CY2016 amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.1 pure
CY2016 amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60
CY2016 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
7900000
CY2014 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
5100000
CY2015 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
6100000
CY2015 amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.64 pure
CY2016 amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.61 pure
CY2016Q4 amed Percentage Of Patient Receivables Outstanding Over Ten Percent
PercentageOfPatientReceivablesOutstandingOverTenPercent
0.101 pure
CY2014Q4 amed Internally Developed Computer Software
InternallyDevelopedComputerSoftware
75800000
CY2016Q4 amed Building And Leasehold Improvements
BuildingAndLeaseholdImprovements
6900000
CY2016Q4 amed Equipment And Furniture
EquipmentAndFurniture
71900000
CY2016Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
96800000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
175600000
CY2015Q4 amed Building And Leasehold Improvements
BuildingAndLeaseholdImprovements
2300000
CY2015Q4 amed Equipment And Furniture
EquipmentAndFurniture
89600000
CY2015Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
92600000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
184500000
CY2016 us-gaap Depreciation
Depreciation
17200000
CY2015 us-gaap Depreciation
Depreciation
20000000
CY2014 us-gaap Depreciation
Depreciation
28000000
CY2016Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
2700000
CY2015Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
3400000
CY2016 amed Unamortized Debt Issuance Cost Amortizatin Period
UnamortizedDebtIssuanceCostAmortizatinPeriod
P3Y8M12D
CY2014 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2000000
CY2016 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
6400000
CY2015 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2015 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
0 shares
CY2014 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1000 shares
CY2014 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
521000 shares
CY2015 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4700000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
221000 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
922000 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
106000 shares
CY2016 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
162000 shares
CY2016 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
381000 shares
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
6900000
CY2015Q4 amed Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Workers Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsWorkersCompensation
9800000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5000000
CY2016 us-gaap Advertising Expense
AdvertisingExpense
7800000
CY2015 us-gaap Advertising Expense
AdvertisingExpense
6900000
CY2014 us-gaap Advertising Expense
AdvertisingExpense
4700000
CY2015 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1322200000
CY2015 amed Businessacquisitionproformaoperatingincomeloss
Businessacquisitionproformaoperatingincomeloss
-7800000
CY2015 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
400000
CY2016 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1449700000
CY2016 amed Businessacquisitionproformaoperatingincomeloss
Businessacquisitionproformaoperatingincomeloss
53900000
CY2016 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
35000000
CY2016 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
1.04
CY2016 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
1.03
CY2015 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.01
CY2015 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.01
CY2014 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-300000
CY2014 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-100000
CY2013Q4 us-gaap Goodwill
Goodwill
208900000
CY2014Q4 us-gaap Goodwill
Goodwill
205600000
CY2016 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
27100000
CY2015 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
56100000
CY2014 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
-3300000
CY2016 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
100000
CY2014 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
3100000
CY2016Q4 amed Legal And Other Settlements
LegalAndOtherSettlements
5700000
CY2016Q4 amed Lease Liability
LeaseLiability
400000
CY2016Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
95700000
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33200000
CY2015 amed Other Intangible Assets Additions
OtherIntangibleAssetsAdditions
11100000
CY2016 amed Other Intangible Assets Additions
OtherIntangibleAssetsAdditions
5200000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2500000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
36700000
CY2015 amed Other Intangibles Write Offs
OtherIntangiblesWriteOffs
300000
CY2014 amed Other Intangibles Write Offs
OtherIntangiblesWriteOffs
200000
CY2016 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P1Y10M24D
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2700000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2200000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
0
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
0
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
0
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4900000
CY2016Q4 amed Payroll Tax Escrow
PayrollTaxEscrow
6700000
CY2015Q4 amed Payroll Tax Escrow
PayrollTaxEscrow
6200000
CY2015Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
500000
CY2015Q4 us-gaap Due From Joint Ventures Current
DueFromJointVenturesCurrent
1800000
CY2015Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
6100000
CY2016Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1300000
CY2016Q4 us-gaap Due From Joint Ventures Current
DueFromJointVenturesCurrent
1700000
CY2016Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1600000
CY2016Q4 amed Workers Compensation Deposits
WorkersCompensationDeposits
400000
CY2015Q4 amed Workers Compensation Deposits
WorkersCompensationDeposits
300000
CY2016Q4 amed Health Insurance Deposits
HealthInsuranceDeposits
500000
CY2015Q4 amed Health Insurance Deposits
HealthInsuranceDeposits
1200000
CY2015Q4 amed Other Miscellaneous Deposits
OtherMiscellaneousDeposits
1500000
CY2016Q4 amed Other Miscellaneous Deposits
OtherMiscellaneousDeposits
900000
CY2015Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
25700000
CY2016Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
27800000
CY2016Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
8900000
CY2015Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
4100000
CY2016Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
10600000
CY2016Q4 amed Charity Care
CharityCare
1400000
CY2016Q4 amed Estimated Medicare Cap Liability
EstimatedMedicareCapLiability
800000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6100000
CY2015Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
11700000
CY2015Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
23900000
CY2015Q4 amed Legal And Other Settlements
LegalAndOtherSettlements
10500000
CY2015Q4 amed Lease Liability
LeaseLiability
600000
CY2015Q4 amed Charity Care
CharityCare
700000
CY2015Q4 amed Estimated Medicare Cap Liability
EstimatedMedicareCapLiability
1400000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6600000
CY2016Q4 amed Hospice Cost Of Revenue
HospiceCostOfRevenue
7200000
CY2015Q4 amed Hospice Cost Of Revenue
HospiceCostOfRevenue
6800000
CY2016Q4 amed Oig Self Disclsoure Accrual
OigSelfDisclsoureAccrual
0
CY2015Q4 amed Oig Self Disclsoure Accrual
OigSelfDisclsoureAccrual
4700000
CY2015Q4 amed Patient Liability
PatientLiability
5100000
CY2016Q4 amed Patient Liability
PatientLiability
4300000
CY2016Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
26800000
CY2016Q4 amed Deferred Compensation Plan Liability
DeferredCompensationPlanLiability
1800000
CY2016Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
1600000
CY2016Q4 amed Uncertain Tax Benefits In Long Term Obligations
UncertainTaxBenefitsInLongTermObligations
300000
CY2015Q4 amed Uncertain Tax Benefits In Long Term Obligations
UncertainTaxBenefitsInLongTermObligations
700000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
96600000
CY2016Q4 amed Total Leverage Ratio
TotalLeverageRatio
1.0 pure
CY2016Q4 amed Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
3.8 pure
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
87800000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
91600000
CY2015Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
300000000
CY2015 us-gaap Debt Issuance Costs
DebtIssuanceCosts
2400000
CY2015Q3 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
2500000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
93000000
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5200000
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
10500000
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
10000000
CY2015Q4 amed Deferred Compensation Plan Liability
DeferredCompensationPlanLiability
2800000
CY2015Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
900000
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
70000000
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-13900000
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.366 pure
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-500000
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-100000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-600000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
22100000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2400000
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
500000
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2200000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2700000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7800000
CY2015Q4 us-gaap Deferred Tax Assets Other Loss Carryforwards
DeferredTaxAssetsOtherLossCarryforwards
48500000
CY2016Q4 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
23200000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
300000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4800000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
155700000
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
143000000
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
30200000
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-100000
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-500000
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
21000000
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1600000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-15000000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-1100000
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
100000
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-100000
CY2016 amed Deferred Income Taxes For Continuing Operations
DeferredIncomeTaxesForContinuingOperations
24500000
CY2015 amed Deferred Income Taxes For Continuing Operations
DeferredIncomeTaxesForContinuingOperations
-700000
CY2014 amed Deferred Income Taxes For Continuing Operations
DeferredIncomeTaxesForContinuingOperations
22700000
CY2016 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2015 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2014 amed Income Tax Effects Allocated To Interest Expense
IncomeTaxEffectsAllocatedToInterestExpense
-100000
CY2015 amed Income Tax Effects Allocated To Interest Expense
IncomeTaxEffectsAllocatedToInterestExpense
200000
CY2016 amed Income Tax Effects Allocated To Interest Expense
IncomeTaxEffectsAllocatedToInterestExpense
-100000
CY2016 us-gaap Income Tax Effects Allocated Directly To Equity Other
IncomeTaxEffectsAllocatedDirectlyToEquityOther
-7200000
CY2015 us-gaap Income Tax Effects Allocated Directly To Equity Other
IncomeTaxEffectsAllocatedDirectlyToEquityOther
-2100000
CY2014 us-gaap Income Tax Effects Allocated Directly To Equity Other
IncomeTaxEffectsAllocatedDirectlyToEquityOther
600000
CY2016 amed Income Tax Effects Allocated To Goodwill
IncomeTaxEffectsAllocatedToGoodwill
0
CY2015 amed Income Tax Effects Allocated To Goodwill
IncomeTaxEffectsAllocatedToGoodwill
-100000
CY2014 amed Income Tax Effects Allocated To Goodwill
IncomeTaxEffectsAllocatedToGoodwill
0
CY2016 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
16600000
CY2015 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
0
CY2014 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
8100000
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.048 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.001 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.006 pure
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.389 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
1.360 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.791 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.071 pure
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-6.506 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.015 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.084 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.058 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.01 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-2.303 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.006 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.006 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-6.633 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.021 pure
CY2016Q4 amed Deferred Tax Assets Other Current
DeferredTaxAssetsOtherCurrent
1100000
CY2015Q4 amed Deferred Tax Assets Other Current
DeferredTaxAssetsOtherCurrent
4000000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
6400000
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
7800000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
107900000
CY2015Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
9500000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
125200000
CY2016Q4 amed Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Workers Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsWorkersCompensation
10900000
CY2015Q4 amed Deferred Tax Assets Goodwill And Intangible Assets1
DeferredTaxAssetsGoodwillAndIntangibleAssets1
72200000
CY2016Q4 amed Deferred Tax Assets Goodwill And Intangible Assets1
DeferredTaxAssetsGoodwillAndIntangibleAssets1
56300000
CY2016Q4 us-gaap Deferred Tax Assets Other Loss Carryforwards
DeferredTaxAssetsOtherLossCarryforwards
44200000
CY2015Q4 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
18500000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
400000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4700000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
143400000
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
155400000
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
35100000
CY2015Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2000000
CY2016Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
900000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
11400000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
5100000
CY2015Q4 us-gaap Deferred Tax Liabilities Investment In Noncontrolled Affiliates
DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
200000
CY2016Q4 us-gaap Deferred Tax Liabilities Investment In Noncontrolled Affiliates
DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
3200000
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
100000
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-300000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
1000000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4700000
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
11400000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0
CY2015 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
300000
CY2016 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
600000
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
200000
CY2016 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
-100000
CY2015 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
200000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4100000
CY2017 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-300000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4000000
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
100000
CY2016 amed Number Of Individual States Subject To Income Tax
NumberOfIndividualStatesSubjectToIncomeTax
50 States
CY2016 amed Percentageofownershipinsubsidiaries
Percentageofownershipinsubsidiaries
0.5 pure
CY2016 amed Percentageoftotalcombinedvotingpowerofthecompanyandoursubsidiaries
Percentageoftotalcombinedvotingpowerofthecompanyandoursubsidiaries
0.1 pure
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1200000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
5500000 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
0.85 pure
CY2016Q4 amed Common Stock Shares Authorized For Issuance To Employee Stock Purchase Plan
CommonStockSharesAuthorizedForIssuanceToEmployeeStockPurchasePlan
1460800 shares
CY2015 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
400000
CY2014 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
400000
CY2016 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
3039200 shares
CY2016 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
400000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11900000
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3900000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2016 amed Corporate Integrity Agreement Term
CorporateIntegrityAgreementTerm
P5Y
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
200000
CY2015 amed Health Insurance
HealthInsurance
11700000
CY2015 amed Wokers Compensation
WokersCompensation
23900000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
17500000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
13000000
CY2016 amed Estimated Insurance Long Term Portion
EstimatedInsuranceLongTermPortion
-800000
CY2016 amed Estimated Insurance Excluding Long Term Portion
EstimatedInsuranceExcludingLongTermPortion
41300000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
23500000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
9100000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
4300000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4600000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
72000000
CY2016 amed Operating Leases Rent Expense Net For Continuing Operations
OperatingLeasesRentExpenseNetForContinuingOperations
27500000
CY2015 amed Operating Leases Rent Expense Net For Continuing Operations
OperatingLeasesRentExpenseNetForContinuingOperations
23700000
CY2014 amed Operating Leases Rent Expense Net For Continuing Operations
OperatingLeasesRentExpenseNetForContinuingOperations
26500000
CY2016 amed Health Insurance
HealthInsurance
10600000
CY2016 amed Wokers Compensation
WokersCompensation
26800000
CY2016 amed Professional Liability
ProfessionalLiability
4700000
CY2016 amed Estimated Insurance Total
EstimatedInsuranceTotal
42100000
CY2015 amed Professional Liability
ProfessionalLiability
4100000
CY2015 amed Estimated Insurance Total
EstimatedInsuranceTotal
39700000
CY2015 amed Estimated Insurance Long Term Portion
EstimatedInsuranceLongTermPortion
-900000
CY2015 amed Estimated Insurance Excluding Long Term Portion
EstimatedInsuranceExcludingLongTermPortion
38800000
CY2016 amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
900000
CY2016 amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
500000
CY2016 amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000
CY2016 amed Minimum Eligible Age For Employees To Contribute To Benefit Plan
MinimumEligibleAgeForEmployeesToContributeToBenefitPlan
21
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6900000
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6100000
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6200000
CY2016 amed Defined Contribution Plan Employer Matching Contribution
DefinedContributionPlanEmployerMatchingContribution
0.375
CY2016 amed Defined Contribution Plan Employee Contribution For Employee Matching Program
DefinedContributionPlanEmployeeContributionForEmployeeMatchingProgram
1.00
CY2016 amed Defind Contribution Plan Maximum Annual Match Per Employee Salary Percentage
DefindContributionPlanMaximumAnnualMatchPerEmployeeSalaryPercentage
0.06 pure
CY2015 amed Defind Contribution Plan Maximum Annual Match Per Employee Salary Percentage
DefindContributionPlanMaximumAnnualMatchPerEmployeeSalaryPercentage
0.06 pure
CY2015 amed Defined Contribution Plan Employee Contribution For Employee Matching Program
DefinedContributionPlanEmployeeContributionForEmployeeMatchingProgram
1.00
CY2015 amed Defined Contribution Plan Employer Matching Contribution
DefinedContributionPlanEmployerMatchingContribution
0.375
CY2014 amed Defined Contribution Plan Employer Matching Contribution
DefinedContributionPlanEmployerMatchingContribution
0.375
CY2014 amed Defined Contribution Plan Employee Contribution For Employee Matching Program
DefinedContributionPlanEmployeeContributionForEmployeeMatchingProgram
1.00
CY2014 amed Defind Contribution Plan Maximum Annual Match Per Employee Salary Percentage
DefindContributionPlanMaximumAnnualMatchPerEmployeeSalaryPercentage
0.06 pure
CY2017 amed Defined Contribution Plan Employer Matching Contribution
DefinedContributionPlanEmployerMatchingContribution
0.440
CY2017 amed Defined Contribution Plan Employee Contribution For Employee Matching Program
DefinedContributionPlanEmployeeContributionForEmployeeMatchingProgram
1.00
CY2017 amed Defind Contribution Plan Maximum Annual Match Per Employee Salary Percentage
DefindContributionPlanMaximumAnnualMatchPerEmployeeSalaryPercentage
0.06 pure
CY2015Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000
CY2015 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
116859 shares
CY2015 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
39.20
CY2016 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
324141 shares
CY2016 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
37.96
CY2016 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segments
CY2016 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
503400000
CY2015 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
452400000
CY2014 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
441700000
CY2015Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
301600000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-35000000
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2015Q4 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
338400000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
12900000
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2016Q4 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
366300000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
8900000
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
10700000
CY2016Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
360700000
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2016Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
361600000
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
10600000
CY2015Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
314100000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
8400000
CY2015Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
326400000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2016Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
348800000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
6200000

Files In Submission

Name View Source Status
0001193125-17-063925-index-headers.html Edgar Link pending
0001193125-17-063925-index.html Edgar Link pending
0001193125-17-063925.txt Edgar Link pending
0001193125-17-063925-xbrl.zip Edgar Link pending
amed-20161231.xml Edgar Link completed
amed-20161231.xsd Edgar Link pending
amed-20161231_cal.xml Edgar Link unprocessable
amed-20161231_def.xml Edgar Link unprocessable
amed-20161231_lab.xml Edgar Link unprocessable
amed-20161231_pre.xml Edgar Link unprocessable
d332070d10k.htm Edgar Link pending
d332070dex1015.htm Edgar Link pending
d332070dex103.htm Edgar Link pending
d332070dex211.htm Edgar Link pending
d332070dex231.htm Edgar Link pending
d332070dex311.htm Edgar Link pending
d332070dex312.htm Edgar Link pending
d332070dex321.htm Edgar Link pending
d332070dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g332070g58p88.jpg Edgar Link pending
g332070g66x66.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending